209 related articles for article (PubMed ID: 14556042)
1. Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists.
Montastuc JL; Bongard V; Lapeyre-Mestre M
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):685-8. PubMed ID: 14556042
[TBL] [Abstract][Full Text] [Related]
2. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.
Patino FG; Allison J; Olivieri J; Mudano A; Juarez L; Person S; Mikuls TR; Moreland L; Kovac SH; Saag KG
Arthritis Rheum; 2003 Jun; 49(3):293-9. PubMed ID: 12794782
[TBL] [Abstract][Full Text] [Related]
3. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.
Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ;
Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673
[TBL] [Abstract][Full Text] [Related]
4. Coxibs: evolution of prescription's behaviour in France.
Biga J; Gony M; Bourrel R; Souche A; Sommet A; Pathak A; Sciortino V; Taboulet F; Grand A; Lapeyre-Mestre M; Montastruc JL
Fundam Clin Pharmacol; 2007 Jun; 21(3):317-25. PubMed ID: 17521301
[TBL] [Abstract][Full Text] [Related]
5. Global safety of coxibs and NSAIDs.
Pham K; Hirschberg R
Curr Top Med Chem; 2005; 5(5):465-73. PubMed ID: 15974941
[TBL] [Abstract][Full Text] [Related]
6. Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students.
Durrieu G; Hurault C; Damase-Michel C; Montastruc JL
Fundam Clin Pharmacol; 2010 Aug; 24(4):423-7. PubMed ID: 19845768
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
8. [Prescription of cyclooxygenase-2 inhibitors: an intervention strategy in primary care].
Rosich I; Soler M; Tomás R; Crusat D
Gac Sanit; 2005; 19(3):229-34. PubMed ID: 15960956
[TBL] [Abstract][Full Text] [Related]
9. Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.
Bongard V; Ménard-Taché S; Bagheri H; Kabiri K; Lapeyre-Mestre M; Montastruc JL
Br J Clin Pharmacol; 2002 Oct; 54(4):433-6. PubMed ID: 12392593
[TBL] [Abstract][Full Text] [Related]
10. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
11. Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.
Phueanpinit P; Pongwecharak J; Sumanont S; Krska J; Jarernsiripornkul N
J Eval Clin Pract; 2017 Dec; 23(6):1387-1394. PubMed ID: 28809071
[TBL] [Abstract][Full Text] [Related]
12. [Serious gastrointestinal effects of nonsteroidal anti-inflammatory drugs (NSAIDS) in a prospective study in Morocco].
Benkirane R; El Kihal L; Nabil S; Benchekroun-Belabbés A; El Feydi AE; Soulaymani R
Sante; 2005; 15(2):113-7. PubMed ID: 16061449
[TBL] [Abstract][Full Text] [Related]
13. Coxibs and NSAIDs--clearing the air.
Moskowitz RW; Abramson SB; Berenbaum F
Osteoarthritis Cartilage; 2005 Jul; 13(7):545-7. PubMed ID: 15979006
[No Abstract] [Full Text] [Related]
14. Patients' knowledge of adverse reactions to current medications.
Cullen G; Kelly E; Murray FE
Br J Clin Pharmacol; 2006 Aug; 62(2):232-6. PubMed ID: 16842399
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs.
Gunnarsdóttir AI; Kinnear M
Pharm World Sci; 2005 Aug; 27(4):316-20. PubMed ID: 16228631
[TBL] [Abstract][Full Text] [Related]
16. Reducing NSAID-induced gastrointestinal complications.
Drug Ther Bull; 2011 Feb; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
[TBL] [Abstract][Full Text] [Related]
17. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
García Rodríguez LA; Barreales Tolosa L
Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
[TBL] [Abstract][Full Text] [Related]
19. Current status of nonsteroidal anti-inflammatory drugs in physiatry: balancing risks and benefits in pain management.
Kaplan RJ
Am J Phys Med Rehabil; 2005 Nov; 84(11):885-94. PubMed ID: 16244527
[TBL] [Abstract][Full Text] [Related]
20. Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].
Doupe M; Katz A; Kvern B; Manness LJ; Metge C; Thomson GT; Morrison L; Rother K
BMC Health Serv Res; 2004 Aug; 4(1):21. PubMed ID: 15327694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
